Valuation Sanofi

Stocks

Market Closed - Euronext Paris 16:55:00 15/10/2026 BST			After hours 20:59:57
72.16 ^EUR	+0.47%		72.18	+0.02%

06:59pm	Sanofi Signs Letter of Intent With Canadian Drug Alliance for Dupixent in Four Additional Indications	MT
03:36pm	Recursion Pharmaceuticals, Inc. Announces Sanofi Options Potential First-In-Class Immunology Development Candidate From Their Collaboration	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	111,194	112,665	112,549	116,968	100,655	86,453	-	-
Change	-	1.32%	-0.1%	3.93%	-13.95%	-14.11%	-	-
Enterprise Value (EV) ¹	121,177	119,102	120,342	125,740	111,663	97,788	94,456	91,625
Change	-	-1.71%	1.04%	4.49%	-11.2%	-12.43%	-3.41%	-3%
P/E	17.8x	16.7x	20.8x	20.4x	12.9x	11.7x	10.1x	8.67x
PBR	1.62x	1.5x	1.52x	1.51x	1.41x	1.17x	1.1x	1.04x
PEG	-	2.07x	-1.1x	3.14x	0.3x	-3.12x	0.6x	0.5x
Capitalization / Revenue	2.94x	2.62x	2.61x	2.85x	2.31x	1.82x	1.71x	1.62x
EV / Revenue	3.21x	2.77x	2.79x	3.06x	2.56x	2.06x	1.87x	1.72x
EV / EBITDA	9.95x	8.14x	8.44x	9.76x	8.22x	6.61x	5.99x	5.34x
EV / EBIT	11.3x	9.13x	9.5x	11.1x	9.19x	7.42x	6.83x	6.07x
EV / FCF	15x	14x	14.2x	21.1x	13.8x	11.9x	10.5x	9.14x
FCF Yield	6.68%	7.12%	7.04%	4.74%	7.24%	8.42%	9.51%	10.9%
Dividend per Share ²	3.33	3.56	3.76	3.92	4.12	4.256	4.502	4.801
Rate of return	3.76%	3.96%	4.19%	4.18%	4.98%	5.9%	6.24%	6.65%
EPS ²	4.97	5.37	4.31	4.59	6.4	6.16	7.172	8.326
Distribution rate	67%	66.3%	87.2%	85.4%	64.4%	69.1%	62.8%	57.7%
Net sales ¹	37,761	42,997	43,070	41,081	43,626	47,373	50,474	53,227
EBITDA ¹	12,183	14,627	14,259	12,889	13,583	14,805	15,779	17,145
EBIT ¹	10,714	13,040	12,670	11,343	12,149	13,180	13,837	15,083
Net income ¹	6,223	6,720	5,400	5,744	7,813	7,309	8,854	10,300
Net Debt ¹	9,983	6,437	7,793	8,772	11,008	11,336	8,004	5,173
Reference price ²	88.58	89.84	89.76	93.74	82.72	72.16	72.16	72.16
Nbr of stocks (in thousands)	1,255,293	1,254,060	1,253,891	1,247,793	1,216,810	1,198,069	-	-
Announcement Date	04/02/22	03/02/23	01/02/24	30/01/25	29/01/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SANOFI	11.67x	2.06x	6.58x	5.93%	95.7B
ELI LILLY AND COMPANY	34.58x	12.46x	26.12x	0.57%	1,077B
JOHNSON & JOHNSON	37.53x	6.26x	17.55x	2.1%	612B
ABBVIE INC.	36.12x	8.31x	17.13x	2.45%	501B
MERCK & CO., INC.	113.84x	6x	25.7x	2.32%	364B
ROCHE HOLDING AG	20.01x	4.88x	12.13x	2.7%	353B
NOVARTIS AG	20.46x	5.37x	13.21x	2.96%	278B
ASTRAZENECA PLC	21.15x	4.27x	12.26x	2.07%	251B
AMGEN INC.	27.06x	6.97x	12.48x	2.37%	230B
GILEAD SCIENCES, INC.	-44.86x	6.85x	26.64x	2.14%	190B
Average	27.76x	6.34x	16.98x	2.56%	395.22B
Weighted average by Cap.	34.55x	7.84x	19.33x	1.97%